|
English
|
正體中文
|
简体中文
|
2809385
|
|
???header.visitor??? :
26959893
???header.onlineuser??? :
1299
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"pang y k"???jsp.browse.items-by-author.description???
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2022-06-27T06:59:36Z |
Olmutinib in T790M-positive non–small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study
|
Park K.; J?nne P.A.; Kim D.-W.; Han J.-Y.; Wu M.-F.; Lee J.-S.; Kang J.-H.; Lee D.H.; Cho B.C.; CHONG-JEN YU; Pang Y.K.; Felip E.; Kim H.; Baek E.; Noh Y.S. |
| 臺大學術典藏 |
2021-05-02T03:29:22Z |
Olmutinib in T790M-positive non–small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study
|
Park K.; J?nne P.A.; Kim D.-W.; Han J.-Y.; Wu M.-F.; Lee J.-S.; Kang J.-H.; Lee D.H.; Cho B.C.; CHONG-JEN YU; Pang Y.K.; Felip E.; Kim H.; Baek E.; Noh Y.S. |
| 國立成功大學 |
2019 |
Tissue and plasma EGFR mutation analysis in the FLAURA trial: Osimertinib versus Comparator EGFR tyrosine kinase inhibitor as first-line treatment in patients with EGFR-mutated advanced non–small cell lung cancer
|
Gray, J.E.;Okamoto, I.;Sriuranpong, V.;Vansteenkiste, J.;Imamura, F.;Lee, J.S.;Pang, Y.-K.;Cobo, M.;Kasahara, Kasahara K.;Cheng, Y.;Nogami, Nogami N.;Cho, E.K.;Su, W.C.;Zhang, G.;Huang, X.;Li-Sucholeiki, X.;Lentrichia, B.;Dearden, S.;Jenkins, S.;Saggese, M.;Rukazenkov, Y.;Ramalingam, S.S. |
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
